Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.91

+1.5%

Nov 18 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2121)	2/4/2008 11:02:41 AM
From: Jibacoa	Read Replies (1) of 3722

SGP Is trying to get above the $21 level. Volume is now > 4.7M bigcharts.marketwatch.com It announced today that the FDA has approved its ASMANEX TWISTHALER 110 mcg for treatment of asthma as a preventive therapy in patients 4 to 11 years of age. (The 220 mcg was approved on Mar 2005 for treatment in patients > 11 years of age.) Of course, the Vitorin problems will affect SGP > MRK & SGP has now a good amount of resistance at the $25 level. bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next